NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $59.94 million. The enterprise value is $141.75 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.99 million shares outstanding. The number of shares has increased by 5.51% in one year.
| Current Share Class | 8.99M |
| Shares Outstanding | 8.99M |
| Shares Change (YoY) | +5.51% |
| Shares Change (QoQ) | +4.76% |
| Owned by Insiders (%) | 8.48% |
| Owned by Institutions (%) | 12.90% |
| Float | 3.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.09 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70
| Current Ratio | 0.70 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.96% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 15.59% |
| Revenue Per Employee | $903,083 |
| Profits Per Employee | -$136,712 |
| Employee Count | 986 |
| Asset Turnover | 1.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NeueHealth has paid $2.21 million in taxes.
| Income Tax | 2.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.87% in the last 52 weeks. The beta is 0.59, so NeueHealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +19.87% |
| 50-Day Moving Average | 6.82 |
| 200-Day Moving Average | 6.47 |
| Relative Strength Index (RSI) | 38.05 |
| Average Volume (20 Days) | 7,171 |
Short Selling Information
The latest short interest is 18,930, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 18,930 |
| Short Previous Month | 13,372 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
In the last 12 months, NeueHealth had revenue of $890.44 million and -$134.80 million in losses. Loss per share was -$15.83.
| Revenue | 890.44M |
| Gross Profit | 215.55M |
| Operating Income | -25.69M |
| Pretax Income | -994.38M |
| Net Income | -134.80M |
| EBITDA | -11.47M |
| EBIT | -25.69M |
| Loss Per Share | -$15.83 |
Full Income StatementBalance Sheet
The company has $145.56 million in cash and $213.43 million in debt, giving a net cash position of -$81.82 million or -$9.10 per share.
| Cash & Cash Equivalents | 145.56M |
| Total Debt | 213.43M |
| Net Cash | -81.82M |
| Net Cash Per Share | -$9.10 |
| Equity (Book Value) | -393.06M |
| Book Value Per Share | -152.26 |
| Working Capital | -268.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.94 million and capital expenditures -$4.11 million, giving a free cash flow of -$74.05 million.
| Operating Cash Flow | -69.94M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | -74.05M |
| FCF Per Share | -$8.23 |
Full Cash Flow StatementMargins
Gross margin is 24.21%, with operating and profit margins of -2.88% and -9.20%.
| Gross Margin | 24.21% |
| Operating Margin | -2.88% |
| Pretax Margin | -6.84% |
| Profit Margin | -9.20% |
| EBITDA Margin | -1.29% |
| EBIT Margin | -2.88% |
| FCF Margin | n/a |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.51% |
| Shareholder Yield | -5.51% |
| Earnings Yield | -224.90% |
| FCF Yield | -123.55% |
Analyst Forecast
The average price target for NeueHealth is $7.00, which is 5.03% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | 5.03% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:80.
| Last Split Date | May 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |